Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Platelet-rich plasma can improve erectile function in older individuals by reducing prostate enlargement.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Saw palmetto extract is generally safe and can effectively treat Lower Urinary Tract Symptoms, but its evaluation is affected by varying quality and a need for long-term studies.

Hair loss linked to kidney stones in people under 60.

Finasteride lowers good cholesterol, raises bad fats, and may increase heart disease risk.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Precise objectives can improve student achievement in health education.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

CT scans can find serious prostate cancer even when PSA levels are low.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Chemical fingerprints can distinguish Eclipta prostrata from Wedelia calendulacea to prevent confusion and adulteration.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Urinary PSA could be an early marker for enlarged prostate.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

The PW91 method is best for calculating the basic physical and chemical properties of Finasteride, a drug used for prostate issues and hair loss.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.